Open access · Peer reviewed · Scopus journal
The National Formulary of India 2010: Thorough and extensive revision of the preprint version needed
- 1*
- 1Programme, National Polio Surveillance Project, and others have been left out.[3] It is diffi cult to believe that such a large group of experts did not know that the list of national health programs was incomplete. The source of reference given is the Ministry of Health and Family Welfare website. Anyone who has accessed government websites in India will know that these are notorious for their incomplete and out of date information.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: B. Gitanjali
Programme, National Polio Surveillance Project, and others have been left out.[3] It is diffi cult to believe that such a large group of experts did not know that the list of national health programs was incomplete. The source of reference given is the Ministry of Health and Family Welfare website. Anyone who has accessed government websites in India will know that these are notorious for their incomplete and out of date information.
Email: gita.batman@gmail.com
Copyright: © 2011 The Author(s). This is an open access article.
Abstract
The National Formulary of India (NFI), 4th edition, 2010 (pre-print version) was published amidst a lot of advance publicity by the Indian Pharmacopoeia Commission (IPC). The book was released by Shri K. Chandramouli, Secretary, Ministry of Health and Family Welfare, Govt. of India and Chairman, IPC on 16th December 2010, at Nirman Bhawan, New Delhi, in the presence of offi cials.[1] Coming after a gap of three decades, the NFI will be a much sought after document for health care providers all over India. The need for unbiased, quality information on medicines is felt all over the country and the NFI 2010 may have been the answer which health professionals were waiting for. However, a quick look at the preprint version of the NFI shows that much work has to be done before the fi nal version is printed.
Keywords
Subject
Recommended articles
- Eminence or Evidence? The Volatility, Uncertainty, Complexity, and Ambiguity in Healthcare
M. K. Unnikrishnan · Journal of Pharmacology and Pharmacotherapeutics
- The three Rs of written assessment: The JIPMER experience
Manikandan S, Gitanjali B · Journal of Pharmacology and Pharmacotherapeutics
- Boosting the brand image
Vijay Thawani, Priyanka Singh, Heenopama Thakur · Journal of Pharmacology and Pharmacotherapeutics
- Trivializing assessment: A key factor in undermining the standards of medical education
Manikandan S · Journal of Pharmacology and Pharmacotherapeutics
- Are we moving towards a new definition of essential medicines?
Manikandan S · Journal of Pharmacology and Pharmacotherapeutics
- Push, promote or educate…musings of a pharmacologist on drug promotion
Chanolean Shashindran · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026